Novartis shutters MorphoSys sites, lays off staff
BioPharma Dive - 19 Dec 2024Novartis shutters MorphoSys sites, lays off staff ...
morphosys
Novartis shutters MorphoSys sites, lays off staff ...
Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years
Fierce Biotech - 29 Oct 2024Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years ...
Novartis to shutter 2 MorphoSys sites, lay off 330 staffers in post-buyout consolidation
Fierce Pharma - 19 Dec 2024Novartis to shutter 2 MorphoSys sites, lay off 330 staffers in post-buyout consolidation ...
MorphoSys Presents Latest Data from the Phase 2 MANIFEST Study Evaluating the Potential of Pelabresib in the Treatment of Myelofibrosis
ACCESS Newswire - 25 Jun 2025MorphoSys Presents Latest Data from the Phase 2 MANIFEST Study Evaluating the Potential of Pelabresib in the Treatment of Myelofibrosis ...
Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bio
Endpoints News - 27 Jun 2025Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bio ...
Endgültiges Aus für Morphosys
Laborjournal - 09 Jan 2025Endgültiges Aus für Morphosys ...
Novartis says 330 jobs hit as it closes MorphoSys sites
Reuters - 19 Dec 2024Novartis says 330 jobs hit as it closes MorphoSys sites ...
Pelabresib delay prompts Novartis to close MorphoSys units, 330 jobs hit
FirstWord Pharma - 19 Dec 2024Pelabresib delay prompts Novartis to close MorphoSys units, 330 jobs hit ...
Swiss pharma giant Novartis to close biotech firm Morphosys
SWI swissinfo.ch - 19 Dec 2024Swiss pharma giant Novartis to close biotech firm Morphosys ...
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
BioSpace - 19 Dec 2024Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs ...
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting
ACCESS Newswire - 25 Jan 2025Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting ...
Biogen refreshes its C-suite; Novartis writes down MorphoSys assets
BioPharma Dive - 29 Oct 2024Biogen refreshes its C-suite; Novartis writes down MorphoSys assets ...
Novartis takes $800M MorphoSys writedown mere months after closing acquisition
Endpoints News - 29 Oct 2024Novartis takes $800M MorphoSys writedown mere months after closing acquisition ...
Novartis gains global rights to Galapagos, MorphoSys' experimental atopic dermatitis drug MOR106
FirstWord Pharma - 17 Apr 2025Novartis gains global rights to Galapagos, MorphoSys' experimental atopic dermatitis drug MOR106 ...
Novartis: launch of Morphosys drug by could be 2027 or later
Reuters - 21 Nov 2024Novartis: launch of Morphosys drug by could be 2027 or later ...
PharmaEssentia nabs MorphoSys GM Horvat to lead its commercial team
Fierce Pharma - 06 Dec 2024PharmaEssentia nabs MorphoSys GM Horvat to lead its commercial team ...
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
ACCESS Newswire - 26 Apr 2025MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act ...
MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab
ACCESS Newswire - 27 Jan 2025MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab ...
MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer
ACCESS Newswire - 26 Apr 2025MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer ...